Cullen/Frost Bankers, Inc. Embecta Corp. Transaction History
Cullen/Frost Bankers, Inc.
- $7.21 Billion
- Q4 2024
A detailed history of Cullen/Frost Bankers, Inc. transactions in Embecta Corp. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 250 shares of EMBC stock, worth $3,367. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 245
2.04%
Holding current value
$3,367
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding EMBC
# of Institutions
407Shares Held
52.4MCall Options Held
120KPut Options Held
66.8K-
Black Rock Inc. New York, NY9.19MShares$124 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.03MShares$94.6 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.27MShares$44.1 Million1.68% of portfolio
-
American Century Companies Inc Kansas City, MO3.26MShares$43.9 Million0.04% of portfolio
-
River Road Asset Management, LLC3.25MShares$43.7 Million0.95% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $779M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...